577 related articles for article (PubMed ID: 23656623)
1. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
Michalski J; Kanaji N; Liu X; Nogel S; Wang X; Basma H; Nakanishi M; Sato T; Gunji Y; Fahrid M; Nelson A; Muller KC; Holz O; Magnussen H; Rabe KF; Toews ML; Rennard SI
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):729-37. PubMed ID: 23043089
[TBL] [Abstract][Full Text] [Related]
3. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E₂ possesses different potencies in inducing Vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts.
Bonanno A; Albano GD; Siena L; Montalbano AM; Riccobono L; Anzalone G; Chiappara G; Gagliardo R; Profita M; Sala A
Prostaglandins Leukot Essent Fatty Acids; 2016 Mar; 106():11-8. PubMed ID: 26926362
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
6. Agonist-specific desensitization of PGE
Nunez FJ; Schulte NA; Fogel DM; Michalski J; Rennard SI; Penn RB; Toews ML; Ostrom RS
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):843-856. PubMed ID: 31884570
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
[TBL] [Abstract][Full Text] [Related]
10. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition.
Selige J; Tenor H; Hatzelmann A; Dunkern T
J Cell Physiol; 2010 May; 223(2):317-26. PubMed ID: 20082309
[TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
[TBL] [Abstract][Full Text] [Related]
14. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
[TBL] [Abstract][Full Text] [Related]
15. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
[TBL] [Abstract][Full Text] [Related]
16. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
17. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
Tannheimer SL; Wright CD; Salmon M
Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.
Nakanishi M; Sato T; Li Y; Nelson AJ; Farid M; Michalski J; Kanaji N; Wang X; Basma H; Patil A; Goraya J; Liu X; Togo S; L Toews M; Holz O; Muller KC; Magnussen H; Rennard SI
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):217-23. PubMed ID: 22298530
[TBL] [Abstract][Full Text] [Related]
19. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.
Bradbury D; Clarke D; Seedhouse C; Corbett L; Stocks J; Knox A
J Biol Chem; 2005 Aug; 280(34):29993-30000. PubMed ID: 15970595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
